loading
전일 마감가:
$16.77
열려 있는:
$16.5
하루 거래량:
34,847
Relative Volume:
0.12
시가총액:
$810.39M
수익:
-
순이익/손실:
$-85.21M
주가수익비율:
-8.7302
EPS:
-1.89
순현금흐름:
$-68.53M
1주 성능:
-1.73%
1개월 성능:
-6.76%
6개월 성능:
-32.48%
1년 성능:
-27.90%
1일 변동 폭
Value
$16.50
$16.95
1주일 범위
Value
$15.91
$17.54
52주 변동 폭
Value
$13.30
$30.03

Enliven Therapeutics Inc Stock (ELVN) Company Profile

Name
명칭
Enliven Therapeutics Inc
Name
전화
720-647-8519
Name
주소
6200 LOOKOUT ROAD, BOULDER
Name
직원
65
Name
트위터
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
ELVN's Discussions on Twitter

ELVN을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
ELVN
Enliven Therapeutics Inc
16.52 874.41M 0 -85.21M -68.53M -1.89
Biotechnology icon
ONC
Beigene Ltd Adr
241.10 24.41B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
432.56 111.55B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.33 42.47M 0 0 0 0.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
586.19 63.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
VRNA
Verona Pharma Plc Adr
73.18 5.92B 0 -153.72M -103.81M -2.00

Enliven Therapeutics Inc Stock (ELVN) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-12-13 개시 BTIG Research Buy
2024-09-09 개시 H.C. Wainwright Buy
2024-06-11 개시 Robert W. Baird Outperform
2024-04-09 개시 Mizuho Buy
2023-03-29 개시 Jefferies Buy

Enliven Therapeutics Inc 주식(ELVN)의 최신 뉴스

pulisher
May 22, 2025

Enliven Therapeutics to Present at Upcoming Investor Conferences - PR Newswire

May 22, 2025
pulisher
May 22, 2025

(ELVN) Proactive Strategies - news.stocktradersdaily.com

May 22, 2025
pulisher
May 22, 2025

Enliven Therapeutics chief scientific officer sells $81,533 in stock - Investing.com Australia

May 22, 2025
pulisher
May 21, 2025

Enliven Therapeutics chief scientific officer sells $81,533 in stock By Investing.com - Investing.com India

May 21, 2025
pulisher
May 20, 2025

Enliven Therapeutics, Inc. (NASDAQ:ELVN) Shares Purchased by Northern Trust Corp - Defense World

May 20, 2025
pulisher
May 19, 2025

HC Wainwright Issues Pessimistic Outlook for ELVN Earnings - Defense World

May 19, 2025
pulisher
May 18, 2025

Jones Trading Has Lowered Expectations for Enliven Therapeutics (NASDAQ:ELVN) Stock Price - Defense World

May 18, 2025
pulisher
May 18, 2025

Q1 Earnings Forecast for ELVN Issued By HC Wainwright - Defense World

May 18, 2025
pulisher
May 17, 2025

HC Wainwright Raises Enliven Therapeutics (NASDAQ:ELVN) Price Target to $40.00 - Defense World

May 17, 2025
pulisher
May 16, 2025

Jones Trading Lowers Price Target for Enliven Therapeutics (ELVN) | ELVN Stock News - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Enliven (ELVN) Stock Target Cut Amid Mixed Market Reaction | ELVN Stock News - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Enliven Therapeutics, Inc. (NASDAQ:ELVN) Holdings Lifted by Price T Rowe Associates Inc. MD - Defense World

May 16, 2025
pulisher
May 16, 2025

Enliven Therapeutics (NASDAQ:ELVN) Stock Price Down 7.6% Following Weak Earnings - Defense World

May 16, 2025
pulisher
May 16, 2025

Enliven Therapeutics Reports Q1 Results and Pipeline Progress - TipRanks

May 16, 2025
pulisher
May 15, 2025

Enliven Therapeutics stock target raised to $40 at H.C. Wainwright By Investing.com - Investing.com South Africa

May 15, 2025
pulisher
May 15, 2025

Enliven Therapeutics: Cash runway can fund ops through late 2027 - BizWest

May 15, 2025
pulisher
May 15, 2025

Enliven Therapeutics (ELVN) Target Price Raised by HC Wainwright & Co. | ELVN Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Enliven Therapeutics stock target raised to $40 at H.C. Wainwright - Investing.com Australia

May 15, 2025
pulisher
May 15, 2025

H.C. Wainwright Increases Price Target for Enliven (ELVN) Post Q - GuruFocus

May 15, 2025
pulisher
May 15, 2025

H.C. Wainwright Increases Price Target for Enliven (ELVN) Post Q1 Report | ELVN Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Enliven reports positive Phase 1 trial data for ELVN-001 in CML - Investing.com Nigeria

May 15, 2025
pulisher
May 15, 2025

Tower Research Capital LLC TRC Boosts Stock Holdings in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World

May 15, 2025
pulisher
May 14, 2025

Enliven Therapeutics Reports First Quarter Financial Results and Provides a Business Update - PR Newswire

May 14, 2025
pulisher
May 14, 2025

Enliven reports positive Phase 1 trial data for ELVN-001 in CML By Investing.com - Investing.com South Africa

May 14, 2025
pulisher
May 14, 2025

Enliven Therapeutics Says ELVN-001 Shows Favorable Safety And Tolerability Profile - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

Enliven Therapeutics Announces Updated Positive Data from Phase 1 Clinical Trial of ELVN-001 in CML and Oral Presentation at the EHA 2025 Congress - The Malaysian Reserve

May 14, 2025
pulisher
May 14, 2025

Enliven (ELVN) Reports Positive Results from ENABLE Trial for Chronic Myeloid Leukemia | ELVN Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Breakthrough CML Drug ELVN-001 Achieves 44% Response Rate in Heavily Pretreated PatientsKey Data Revealed - Stock Titan

May 14, 2025
pulisher
May 11, 2025

(ELVN) Investment Analysis - news.stocktradersdaily.com

May 11, 2025
pulisher
May 11, 2025

Enliven Therapeutics (ELVN) Expected to Announce Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 05, 2025

Wells Fargo & Company MN Has $375,000 Stock Holdings in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World

May 05, 2025
pulisher
May 05, 2025

Invesco Ltd. Buys 508 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World

May 05, 2025
pulisher
May 04, 2025

Barclays PLC Has $1.45 Million Holdings in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World

May 04, 2025
pulisher
May 02, 2025

Enliven Therapeutics (NASDAQ:ELVN) Sets New 52-Week Low on Insider Selling - Defense World

May 02, 2025
pulisher
May 02, 2025

JPMorgan Chase & Co. Trims Stock Position in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World

May 02, 2025
pulisher
May 01, 2025

Enliven (ELVN) Gains Attention as EHA Data Release Approaches | - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Trading (ELVN) With Integrated Risk Controls - news.stocktradersdaily.com

May 01, 2025
pulisher
Apr 30, 2025

Enliven Therapeutics, Inc. (NASDAQ:ELVN) Stake Lowered by Legal & General Group Plc - Defense World

Apr 30, 2025
pulisher
Apr 24, 2025

Enliven Therapeutics chief scientific officer sells $80,365 in stock By Investing.com - Investing.com India

Apr 24, 2025
pulisher
Apr 24, 2025

Enliven Therapeutics chief scientific officer sells $80,365 in stock - Investing.com Australia

Apr 24, 2025
pulisher
Apr 23, 2025

Enliven Therapeutics Inc (ELVN) shows promising results - uspostnews.com

Apr 23, 2025
pulisher
Apr 22, 2025

Enliven Therapeutics: Awaiting Additional Trial Data (NASDAQ:ELVN) - Seeking Alpha

Apr 22, 2025
pulisher
Apr 20, 2025

Geode Capital Management LLC Acquires 12,510 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World

Apr 20, 2025
pulisher
Apr 18, 2025

Can you now get a good deal on Enliven Therapeutics Inc’s shares? - uspostnews.com

Apr 18, 2025
pulisher
Apr 15, 2025

(ELVN) Trading Report - news.stocktradersdaily.com

Apr 15, 2025
pulisher
Apr 13, 2025

Vanguard Group Inc. Purchases 55,283 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World

Apr 13, 2025
pulisher
Apr 13, 2025

Enliven Therapeutics, Inc. (NASDAQ:ELVN) Stake Boosted by Wellington Management Group LLP - Defense World

Apr 13, 2025
pulisher
Apr 11, 2025

KLP Kapitalforvaltning AS Makes New $97,000 Investment in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World

Apr 11, 2025
pulisher
Apr 10, 2025

Ratios Revealed: Decoding Enliven Therapeutics Inc (ELVN)’s Financial Health - DWinneX

Apr 10, 2025
pulisher
Apr 10, 2025

Corebridge Financial Inc. Trims Holdings in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World

Apr 10, 2025
pulisher
Apr 09, 2025

Enliven Therapeutics COO Anish Patel sells shares worth $120,268 By Investing.com - Investing.com India

Apr 09, 2025

Enliven Therapeutics Inc (ELVN) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Enliven Therapeutics Inc 주식 (ELVN) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Kintz Samuel
PRESIDENT AND CEO
May 19 '25
Sale
16.49
5,000
82,453
972,892
$1.19
price down icon 13.67%
$31.50
price down icon 3.35%
$578.71
price down icon 0.54%
$285.13
price down icon 1.30%
$4.10
price down icon 2.24%
$72.94
price down icon 0.11%
자본화:     |  볼륨(24시간):